Претраживање
Приказ резултата 1-10 од 26
Medicines in prevention and therapy of venous thromboembolism / Lekovi u prevenciji i terapiji venskog tromboembolizma
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Venous thromboembolism (VTE) is a frequent cause of morbidity and mortality in our country and in the world. In prevention and therapy of VTE antithrombotic drugs and non- pharmacological measures are being used. The use ...
Herbal medicinal products in dermatology / Primena biljnih lekovitih proizvoda u dermatologiji
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Herbal medicinal products (HMPs) are used in dermatology, primarily for treating inflammatory and infectious diseases, and as an aid in healing of minor injuries (minor wounds and burns). Their pharmacological effects are ...
Ethics in modern pharmaceutical practice / Etika u savremenoj farmaceutskoj praksi
(Komora zdravstvenih ustanova Srbije, Beograd, 2013)
Introduction: According to legal provisions and moral and ethical principles, pharmacists are required to contribute to improving the level and quality of health care services of their professional duties. Modern pharmaceutical ...
Dry skin as a condition and a symptom: The role of dermocosmetic preparations / Suva koža kao stanje i simptom - uloga dermokozmetičkih preparata
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Water is absolutely essential for the normal functioning of the skin and especially its outer layer, the stratum corneum (SC). Loss of water from the skin must be carefully regulated, a function dependent on the complex ...
I1-Imidazoline receptors ligands as central antihypertensives / Ligandi I1-Imidazolinskih receptora sa centralnim antihipertenzivnim dejstvom
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
The mechanism by which central antihypertensives, such as clonidine, rilmenidine, and moxonidine, lower blood pressure is activation of both α2-adrenergic receptors (α2-AR) and imidazoline receptors (IR) in Rostral ...
Biomarkers of prehipertension / Biomarkeri prehipertenzije
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Prehypertension, which was defined as a systolic blood pressure (SBP) between 120 and 139 mmHg or a diastolic blood pressure (DBP) between 80 and 89 mmHg is shown to be associated with a twofold higher risk of cardiovascular ...
Nanomaterials in cosmetic products: Functionality and safety issues / Nanomaterijali u kozmetičkim proizvodima - opravdanost primene i bezbednost
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Nanomaterials in cosmetic products include particles of active ingredients (AI) (nanocrystals, nanoparticles) (e.g., ultrafine/nanoparticles titanium dioxide, zinc oxide, silver, gold) as well as a variety of nanocarriers ...
Pharmaceutical care in the treatment of deep vein thrombosis / Farmaceutska zdravstvena zaštita u terapiji duboke venske tromboze
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Anticoagulation therapy is commonly used in deep vein thrombosis (DVT) prophylaxis associated with surgical interventions and in treatment of patients with DVT, atrial fibrillation and prosthetic heart valves. Long-term ...
Drug - DNA interactions: Properties and detection / Interakcije lekova i DNK- osobine i detekcija
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Large number of inorganic and organic compounds is able to bind to DNA and form the complex. Among them, very important drugs are chemotherapeutics. This paper presents the overview of DNA structural characteristics and ...
Magistral and galenic drugs in dermatology: Past or present / Magistralni i galenski lekovi u dermatologiji - prošlost ili sadašnjost
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Since the majority of registered drugs are available in single dose/strength and dosage form, the importance of drug compounding, especially in respect to treatment of various dermatological conditions, is being re-evaluated. ...